A Colossal $60 million Series A

Colossal Biosciences, the firm pioneering “de-extinction technologies” to restore threatened or even vanished species, announced a $60 million Series A.

Why it matters: The early stage funding announcement comes five months after Colossal raised $15 million in seed capital, bringing the company’s total funding to $75 million.

The big picture: The company straddles climate science and biotech — which is reflected in the investor makeup:

• The funding round was led by billionaire Thomas Tull, CEO of Tulco, as well as At One Ventures, which focuses on sustainability and regenerative technologies.
• It also included Untamed Planet, Animoca Brands, Breyer Capital, Animal Capital, Arch Ventures co-founder Robert Nelsen, Bold Capital, Boost VC, Jazz Ventures, Builders VC, Green Sands Equity, Draper Associates, and Charles Hoskinson. Also, Paris Hilton.

To learn more click here